Screener
Sarepta Therapeutics, Inc. SRPT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.9B.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s market capitalization?
- Sarepta Therapeutics, Inc. (SRPT) reported market capitalization of $1.9B in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s market capitalization changed year-over-year?
- Sarepta Therapeutics, Inc.'s market capitalization increased by 1.7% year-over-year, from $1.87B to $1.9B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s market capitalization has grown at a -30.1% compound annual growth rate (CAGR), from $13.55B to $2.26B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Sarepta Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude